Alimera Sciences

Press Releases

All Releases
View Summary Alimera Sciences' ILUVIEN® Receives Marketing Authorization In The Netherlands For The Treatment Of Chronic Diabetic Macular Edema
Dec 1, 2014
PDF 13.2 KB Add to Briefcase
View Summary Alimera Sciences Announces Agreement with Deerfield Management for $50.0 Million Financing
Nov 28, 2014
PDF 11.6 KB Add to Briefcase
View Summary Alimera Sciences' ILUVIEN® Receives Marketing Authorization In Ireland For The Treatment Of Chronic Diabetic Macular Edema
Nov 17, 2014
PDF 11.8 KB Add to Briefcase
View Summary Alimera Sciences' ILUVIEN® Receives Marketing Authorization In Belgium For The Treatment Of Chronic Diabetic Macular Edema
Nov 12, 2014
PDF 12.1 KB Add to Briefcase
View Summary Alimera Sciences Reports Third Quarter 2014 Financial Results
Nov 6, 2014
PDF 27.4 KB Add to Briefcase
View Summary Alimera Sciences to Release Third Quarter 2014 Results
Oct 23, 2014
PDF 8.7 KB Add to Briefcase
View Summary Alimera Sciences to Present at Ophthalmology Innovation Summit at the American Academy of Ophthalmology Annual Meeting
Oct 9, 2014
PDF 8.2 KB Add to Briefcase
View Summary Alimera Sciences Receives $25 Million Advance from Hercules Technology Growth Capital
Sep 30, 2014
PDF 9.4 KB Add to Briefcase
View Summary Alimera Sciences Provides Details On FDA Approval Of ILUVIEN® As The First Long-Term Treatment For Diabetic Macular Edema
Sep 29, 2014
PDF 17.6 KB Add to Briefcase
View Summary Alimera Sciences Receives FDA Approval For ILUVIEN®, The First Long-Term Treatment For Diabetic Macular Edema
Sep 26, 2014
PDF 11.6 KB Add to Briefcase
View Summary Alimera Sciences' ILUVIEN® Receives Tenth National Marketing Authorization For The Treatment Of Chronic Diabetic Macular Edema
Sep 3, 2014
PDF 13.5 KB Add to Briefcase
View Summary Alimera Sciences Reports Second Quarter 2014 Financial Results
Aug 7, 2014
PDF 32.8 KB Add to Briefcase
View Summary Alimera Sciences' ILUVIEN® Receives Marketing Authorization In Denmark For The Treatment Of Chronic Diabetic Macular Edema
Jul 31, 2014
PDF 13.2 KB Add to Briefcase
View Summary Alimera Sciences' ILUVIEN® Receives Marketing Authorization In Norway For The Treatment Of Chronic Diabetic Macular Edema
Jul 28, 2014
PDF 13.6 KB Add to Briefcase
View Summary Alimera Sciences To Release Second Quarter 2014 Results
Jul 24, 2014
PDF 8.1 KB Add to Briefcase
View Summary Alimera Sciences' ILUVIEN® Receives Positive Outcome Of Repeat-Use Procedure For 10 Additional European Countries
Jun 30, 2014
PDF 12.6 KB Add to Briefcase
View Summary Alimera Sciences' ILUVIEN® Receives Marketing Authorization In Italy For The Treatment Of Chronic Diabetic Macular Edema
Jun 23, 2014
PDF 12.2 KB Add to Briefcase
View Summary Alimera Sciences To Present At Jefferies Healthcare Conference
May 27, 2014
PDF 7.7 KB Add to Briefcase
View Summary Alimera Sciences Reports First Quarter 2014 Financial Results
May 8, 2014
PDF 26.1 KB Add to Briefcase
View Summary Alimera Sciences To Release First Quarter 2014 Results
May 1, 2014
PDF 8.1 KB Add to Briefcase
Showing 61-80 of 205 Page: 1 2 3 4 5 6 7 8 ... 11  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase
/* */